• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA NEAT1-微小 RNA-140 轴通过阻断 AMPK/SREBP-1 信号通路加重非酒精性脂肪性肝病。

LncRNA NEAT1-MicroRNA-140 axis exacerbates nonalcoholic fatty liver through interrupting AMPK/SREBP-1 signaling.

机构信息

Department of Hepatobiliary Surgery, Weihai Municipal Hospital Affiliated to Dalian Medical University, Weihai, China.

Department of Hepatobiliary Surgery, Weihai Municipal Hospital Affiliated to Dalian Medical University, Weihai, China.

出版信息

Biochem Biophys Res Commun. 2019 Aug 20;516(2):584-590. doi: 10.1016/j.bbrc.2019.06.104. Epub 2019 Jun 22.

DOI:10.1016/j.bbrc.2019.06.104
PMID:31239155
Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) is a severe liver disease, which influences the health of people worldwide. However, the mechanism modulating the pathogenesis of NAFLD remains elusive. It was reported that nuclear enriched abundant transcript 1 (NEAT1) and microRNA-140 (miR-140) could regulate lipogenesis, but whether they could influence NAFLD are still unknown.

METHODS

HepG2 cells were treated by free fatty acids (FFA) to establish the model of NAFLD in vitro, and C57 mice were treated by high-fat diet to establish the model of NAFLD in vivo. Cell transfection was applied to regulate the expression of NEAT1 and miR-140. Western blotting and qRT-PCR were applied for measuring expression of protein and mRNA, respectively. HE staining and Oil Red O staining were used for observing liver tissues.

RESULTS

NEAT1 and miR-140 are upregulated in hepacytes under the NAFLD conditions. NEAT1 directly binds to miR-140 and acts synergistically with miR-140 to exacerbate the progression of NAFLD. Reciprocally, silence of miR-140 or NEAT1 alleviates the severity of NAFLD. The mechanistical study shows that the axis of NEAT1-miR-140 inactivates AMPK/SREBP-1 signaling during the NAFLD. .

CONCLUSION

The NEAT1-miR-140 axis play a crucial role in modulation of NAFLD via inactivation of AMPK/SREBP1 signaling. This study may provide a novel insight for the treatment of NAFLD.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是一种严重的肝脏疾病,影响着全球人类的健康。然而,调节 NAFLD 发病机制的机制仍不清楚。有报道称核富集丰富转录本 1(NEAT1)和 microRNA-140(miR-140)可以调节脂肪生成,但它们是否会影响 NAFLD 尚不清楚。

方法

用游离脂肪酸(FFA)处理 HepG2 细胞,在体外建立 NAFLD 模型,用高脂饮食处理 C57 小鼠,在体内建立 NAFLD 模型。采用细胞转染调节 NEAT1 和 miR-140 的表达。采用 Western blot 和 qRT-PCR 分别检测蛋白和 mRNA 的表达。采用 HE 染色和油红 O 染色观察肝组织。

结果

在 NAFLD 条件下,肝细胞中 NEAT1 和 miR-140 表达上调。NEAT1 可直接与 miR-140 结合,并与 miR-140 协同作用,加重 NAFLD 的进展。相反,沉默 miR-140 或 NEAT1 可减轻 NAFLD 的严重程度。机制研究表明,NEAT1-miR-140 轴在 NAFLD 过程中通过抑制 AMPK/SREBP-1 信号通路起作用。

结论

NEAT1-miR-140 轴通过抑制 AMPK/SREBP1 信号通路在调节 NAFLD 中起关键作用。本研究可能为 NAFLD 的治疗提供新的思路。

相似文献

1
LncRNA NEAT1-MicroRNA-140 axis exacerbates nonalcoholic fatty liver through interrupting AMPK/SREBP-1 signaling.长链非编码 RNA NEAT1-微小 RNA-140 轴通过阻断 AMPK/SREBP-1 信号通路加重非酒精性脂肪性肝病。
Biochem Biophys Res Commun. 2019 Aug 20;516(2):584-590. doi: 10.1016/j.bbrc.2019.06.104. Epub 2019 Jun 22.
2
LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease.长链非编码 RNA NEAT1 通过调节非酒精性脂肪性肝病中的 miR-146a-5p/ROCK1 促进肝脂质积累。
Life Sci. 2019 Oct 15;235:116829. doi: 10.1016/j.lfs.2019.116829. Epub 2019 Sep 1.
3
Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathway.沉默长链非编码RNA NEAT1通过调控miR-139-5p/c-Jun/SREBP-1c信号通路减少非酒精性脂肪肝的脂肪沉积。
Ann Hepatol. 2022 Mar-Apr;27(2):100584. doi: 10.1016/j.aohep.2021.100584. Epub 2021 Nov 19.
4
miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.miR-122 通过靶向 Sirt1 抑制 LKB1/AMPK 通路促进非酒精性脂肪性肝病中的肝脂肪生成。
Mol Med. 2019 Jun 13;25(1):26. doi: 10.1186/s10020-019-0085-2.
5
lncRNA NEAT1 regulates fibrosis and inflammatory response induced by nonalcoholic fatty liver by regulating miR-506/GLI3.长链非编码 RNA NEAT1 通过调控 miR-506/GLI3 调节非酒精性脂肪性肝病引起的纤维化和炎症反应。
Eur Cytokine Netw. 2019 Sep 1;30(3):98-106. doi: 10.1684/ecn.2019.0432.
6
Circ_0057558 promotes nonalcoholic fatty liver disease by regulating ROCK1/AMPK signaling through targeting miR-206.环状 RNA 0057558 通过靶向 miR-206 调控 ROCK1/AMPK 信号通路促进非酒精性脂肪性肝病。
Cell Death Dis. 2021 Aug 26;12(9):809. doi: 10.1038/s41419-021-04090-z.
7
Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p/GRIA3.乙酰化的 H3K27 激活长链非编码 RNA NEAT1,并通过调节 miR-212-5p/GRIA3 促进非酒精性脂肪性肝病中的肝脂质积累。
Mol Cell Biochem. 2022 Jan;477(1):191-203. doi: 10.1007/s11010-021-04269-0. Epub 2021 Oct 15.
8
LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.长链非编码 RNA-H19 通过直接调控 miR-130a/PPARγ 轴促进非酒精性脂肪性肝病中的肝脂肪生成。
Biosci Rep. 2019 Jul 15;39(7). doi: 10.1042/BSR20181722. Print 2019 Jul 31.
9
Down-regulation of lncRNA-NEAT1 alleviated the non-alcoholic fatty liver disease via mTOR/S6K1 signaling pathway.lncRNA-NEAT1 的下调通过 mTOR/S6K1 信号通路缓解非酒精性脂肪性肝病。
J Cell Biochem. 2018 Feb;119(2):1567-1574. doi: 10.1002/jcb.26317. Epub 2017 Sep 7.
10
Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2.长链非编码 RNA AC012668 通过与脂蛋白相关蛋白 LRP2 竞争 microRNA miR-380-5p 来抑制非酒精性脂肪性肝病。
Bioengineered. 2021 Dec;12(1):6738-6747. doi: 10.1080/21655979.2021.1960463.

引用本文的文献

1
Advances in the Regulation of Lipid Metabolism by Non-Coding RNAs.非编码RNA对脂质代谢调控的研究进展
Animals (Basel). 2025 Sep 7;15(17):2621. doi: 10.3390/ani15172621.
2
The cancer-associated fibroblast facilitates YAP liquid-liquid phase separation to promote cancer cell stemness in HCC.癌症相关成纤维细胞促进YAP液-液相分离,以促进肝癌中的癌细胞干性。
Cell Commun Signal. 2025 May 24;23(1):238. doi: 10.1186/s12964-025-02256-2.
3
Understanding the Link Between Sterol Regulatory Element Binding Protein (SREBPs) and Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD).
了解固醇调节元件结合蛋白(SREBPs)与代谢功能障碍相关脂肪性肝病(MASLD)之间的联系。
Curr Obes Rep. 2025 Apr 14;14(1):36. doi: 10.1007/s13679-025-00626-y.
4
Identification of tryptophan metabolism-related biomarkers for nonalcoholic fatty liver disease through network analysis.通过网络分析鉴定非酒精性脂肪性肝病中色氨酸代谢相关生物标志物
Endocr Connect. 2025 Apr 23;14(5). doi: 10.1530/EC-24-0470. Print 2025 May 1.
5
Understanding lncRNAs: key regulators of myogenesis and lipogenesis in farm animals.了解长链非编码RNA:家畜肌肉生成和脂肪生成的关键调节因子。
Front Vet Sci. 2025 Feb 14;12:1540613. doi: 10.3389/fvets.2025.1540613. eCollection 2025.
6
Stable Transmission of DNA Methylation Epimutations from Germlines to the Liver and Their Association with Fatty Liver Disease in Medaka.DNA甲基化表观突变从生殖系到肝脏的稳定传递及其与青鳉脂肪肝疾病的关联
Res Sq. 2025 Feb 14:rs.3.rs-6010210. doi: 10.21203/rs.3.rs-6010210/v1.
7
Mechanistic role of long non-coding RNAs in the pathogenesis of metabolic dysfunction-associated steatotic liver disease and fibrosis.长链非编码RNA在代谢功能障碍相关脂肪性肝病和肝纤维化发病机制中的作用机制
eGastroenterology. 2024 Nov;2(4):e100115. doi: 10.1136/egastro-2024-100115. Epub 2024 Nov 18.
8
Long Non-Coding RNAs in Non-Alcoholic Fatty Liver Disease; Friends or Foes?非酒精性脂肪性肝病中的长链非编码RNA:是友是敌?
Cell Biochem Biophys. 2025 Mar;83(1):279-294. doi: 10.1007/s12013-024-01555-8. Epub 2024 Oct 8.
9
SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic Strategies.肝脏疾病中SREBP对脂质代谢的调控及治疗策略
Biomedicines. 2023 Dec 12;11(12):3280. doi: 10.3390/biomedicines11123280.
10
The impact and role of identified long noncoding RNAs in nonalcoholic fatty liver disease: A narrative review.鉴定长非编码 RNA 在非酒精性脂肪性肝病中的作用和影响:叙述性综述。
J Clin Lab Anal. 2023 Jun;37(11-12):e24943. doi: 10.1002/jcla.24943. Epub 2023 Jul 12.